(PGY1 and PGY2 Combined) Investigational Drugs and Research Pharmacy Residency

Dr. Kim Redic, PharmD, BCPS
Residency Program Director

This program is fully accredited by ASHP. 

Program Purpose

PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification.

Description of Program

This two-year specialty residency training program in Investigational Drugs & Research Pharmacy is designed to provide the resident with a wide array of experiences in clinical drug research while affording opportunities for collaboration with renowned clinicians and world class experts in research, education, and population health. The program is designed to provide a strong clinical foundation while developing analytical, leadership, teaching, and writing skills. It will also provide experiences in clinical trial research and research pharmacy staffing experiences. The first year is aligned with the UMHS PGY-1 program, with elective and longitudinal experiences in research-related areas. The PGY-2 year provides specialized experiences in clinical research. Upon completion of the program, the resident will be prepared to secure a specialized pharmacist position in a variety of clinical research, regulatory, and drug development settings, including industry, academia, and research pharmacy practice.

Requirements for Graduation

Graduation requirements are as noted in the Manual, apply to each year separately, and include completion of 80% or more of the ASHP Required Outcomes for each year. It is expected that the requirements for the PGY1 residency be completed wholly within the first year. However, some of the goals and objectives for the PGY2 year can be achieved during the PGY1 year, depending on the rotations selected (e.g. if the PGY1 Clinical Research elective is chosen).

Unless approved by the RP-RAC, the resident is expected to complete separate experiences in each year for each requirement.

Required Rotations

 Most experiences can be configured as either blocks or longitudinal experiences, depending on resident interest and other scheduling considerations. Therefore, requirements are noted in terms of “units,” where a unit is either a 1-month block or equivalent (equivalent to approximately 20 days) completed longitudinally.

  • Orientation: Operations, Study Management, Institutional Review Board (2 units)
  • Research Pharmacy Operations (1 unit)
  • Research Pharmacy Leadership & Practice Management (1 unit)
  • Ambulatory Research Clinic (1 unit)
  • Institutional Review Board/Regulatory Affairs (1 unit)
  • MICHR– Investigator Assistance Program (1 unit)
  • Study Management (1 unit)
  • Clinical Trial Development and Support (1 unit)
  • Research Quality & Safety (1 unit)

Elective Rotations

Any required rotation noted above can be developed into an advanced level elective for residents who wish to develop additional skills or competencies in a specific area.
Patient Care Rotations: any RAC-approved patient care rotation can be developed into an elective in the PGY2 year, and should be considered for residents who want to develop additional clinical competency in a specific patient population. The patient population should include opportunities for care of research participants and/or should develop skills of relevance in the care of research participants.
Additional opportunities for electives that can be considered/explored based on resident interest and alignment with residency goals and objectives.



  • Staffing responsibilities involving operational or clinical work approximately every other weekend.


  • Staffing component of an average one research pharmacist dispensing shift per week. These shifts range from 4-6 hours per shift, occur during the prevailing RP hours of operation, and will be scheduled around other residency requirements.
  • Research Pharmacy on-call rotation, which is comprised of 1-week on-call assignments an average of every 7-12 weeks.

Meeting Attendance

  • As per the Manual, noting the opportunity for request to attend an alternate meeting in lieu of Great Lakes Residency Conference in the PGY2 year.
  • One additional specialty meeting in the PGY2 year (requires RP-RAC approval)

Research and Publications

Through the research and writing requirements of the program, the resident has the potential to produce at least two manuscripts suitable for peer-reviewed publication by the end of each year of the two-year residency

Program Assessment Strategy

The program is structured in accordance with the ASHP Accreditation Standards and ASHP Educational Outcomes, Goals, and Objectives and utilizes the Residency Learning System model. This program has a four-part assessment strategy of learning experiences: resident evaluation of learning experience, resident evaluation of preceptor, resident self-evaluation, and preceptor evaluation of the resident's performance during the learning experience.

Contact Information

Kim Redic, PharmD, BCPS
Program Director & Research Pharmacy Manager
Michigan Medicine, Department of Pharmacy Services

Clinical Assistant Professor 
University of Michigan College of Pharmacy
Phone: (734) 936-9699
Email: kredic@med.umich.edu

PGY-2 Resident: Caitlyn Young, PharmD

PGY-1 Resident: Lauren Quiroga, PharmD

Previous Graduates

Andrew Smith, PharmD (2019-2021)

Jola Mehmeti, PharmD, MBA (2018-2020)

Application Information

Participation in Personnel Placement Service (PPS) at the ASHP Midyear Clinical Meeting is recommended. Applicants are highly encouraged to have prior exposure or rotational experience related to an investigational drug service or the drug development process. Candidates interested in the program should apply online through the Pharmacy Online Residency Centralized Application Services (PhORCAS) and include the following: 

1.  Letter of Interest
2.  Curriculum Vitae
3.  Three Letters of Recommendation
4.  Academic Transcript

Following receipt of the application via PhORCAS, selected qualified candidates will be invited for an interview. Deadline for application is January 1st

Please check out the F.A.Q. for other application deadlines and interview dates.